New landmark report on Telomeres and Telomerase now

available LARCHMONT, N.Y. (PROTEXT) - A special business report, Telomeres and Telomerase: Technology, Players and Opportunities, has been published by Genetic Engineering News (GEN), a division of Mary Ann Liebert, Inc., publishers. This is the only comprehensive report that covers in depth the research and product development based on telomeres and telomerase for both diagnostics and therapeutics related to their applications for cancer and anti-aging medicines. The report includes: -- Information on the 28 most important patents in telomeres and telomerase as well as coverage of the products that have been developed. -- Profiles of, and complete contact information, for over 70 leading pharmaceutical and biotechnology companies and academic groups working in this field. -- A list of major researchers in the field, and information on over 240 NIH/NSF grants. -- Interviews with the 25 leaders in the field from companies that include Amgen, Geron, Avi Biopharma, and Perceptive BioSystems. -- Research developments -- Market statistics The report is available for $1295 from Mary Ann Liebert, Inc., publishers, Two Madison Avenue, Larchmont, New York 10538. Ph: 914-834-3100; e-mail: tmulak@liebertpub.com ots Original Text Service: Mary Ann Liebert, Inc., publishers Internet: http://www.newsaktuell.de Contact: E. Bicovny of Mary Ann Liebert, Inc., publishers, 914-834-3100, ext. 622 Subscribers please note that material bearing the slug "PROTEXT" is not part of CTK's news service and is not to be published under the "CTK" slug. Protext is a commercial service providing distribution of press releases from clients, who are identified in the text of Protext reports and who bear full responsibility for their contents.